Interaction of 1,4-Dihydropyridine and Pyridine Derivatives with Adenosine Receptors: Selectivity for A3 Receptors-Reference-Cited by-同舟云学术

Interaction of 1,4-Dihydropyridine and Pyridine Derivatives with Adenosine Receptors: Selectivity for A3 Receptors

Published:1996-01-01 Issue:15 Volume:39 Page:2980-2989
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

van Rhee A. Michiel¹,Jiang Ji-long¹,Melman Neli¹,Olah Mark E.¹,Stiles Gary L.¹,Jacobson Kenneth A.¹

Affiliation:

1. Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0810, and Departments of Medicine and Pharmacology, Duke University Medical Center, Durham, North Carolina 27710

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm9600205

Reference43 articles.

1. Calcium Antagonists in Comparison

2. 1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structure-activity relationship approach

3. Discovery of .alpha.1a-Adrenergic Receptor Antagonists Based on the L-Type Ca2+ Channel Antagonist Niguldipine

4. 4-Alkyl-1,4-dihydropyridine derivatives as specific PAF-acether antagonists

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tertiary‐Amine Controlled (3+3) or (4+2) Annulations of β′‐Acetoxy Allenoates with N‐Sulfonyl Ketimines: An Entry to m‐Teraryl and Fused Dihydropyridines;Advanced Synthesis & Catalysis;2024-01-23

2. Synthesis, Anticancer Evaluation and in Silico Studies of 1,4‐Dihydropyridines;Chemistry & Biodiversity;2023-07-20

3. In vivo phenotypic validation of adenosine receptor-dependent activity of non-adenosine drugs;Purinergic Signalling;2023-02-13

4. International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update;Pharmacological Reviews;2022-03-17

5. Styryl Group, a Friend or Foe in Medicinal Chemistry;ChemMedChem;2022-03-02